Diabetics who need to switch from oral medications to insulin could reduce their annual healthcare costs up to $17,000 by using an insulin pen instead of a syringe to deliver their daily dose of medication.
A new study found that using an insulin pen may result in fewer trips to the emergency department and to the doctors office, resulting in substantial savings to diabetics and their insurers.
For one, there is less chance of getting the wrong dose of insulin, said Rajesh Balkrishnan, the studys senior author and the Merrell Dow professor of pharmacy at Ohio State University. Diabetics who use syringes must carefully measure their insulin, so there is a risk of getting too much or too little.
The pen contains a pre-measured dose of insulin in a disposable cartridge. Users simply push a button on the pen, and the proper dose of medication is injected through a needle. A syringe user must extract the exact dose of insulin from a vial.
The findings appear in a recent issue of the journal Clinical Therapeutics.
The Centers for Disease Control and Prevention estimates that 21 million people in the United States are diabetic. Experts say the disease accounts for $132 billion in health care expenditures each year.
Balkrishnan and his colleagues followed more than 1,300 diabetic adults enrolled in a Medicaid program in North Carolina. Each patient had failed treatment with oral medications prescribed to control the symptoms of their disease and had begun insulin therapy. Oral drugs are typically the first course of treatment when someone is initially diagnosed with type II diabetes.